CoChat

Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer

Barneh, Farnaz, Mirzaie, Mehdi, Nickchi, Payman, Tan, Tuan Zea, Thiery, Jean Paul, Piran, Mehran, Salimi, Mona, Goshadrou, Fatemeh, Aref, Amir R, Jafari, Mohieddin · 2019 · Briefings in Bioinformatics

Published version of a preprint

Cited by 19

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bib/bby030

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 72

  1. Rhodes, 2004, Bioinformatics strategies for translating genome‐wide expression analyses into clinically useful cancer markers, Ann N Y Acad Sci, 1020, 32, 10.1196/annals.1310.005 · DOI
  2. Sorger, 2011, An NIH white paper by the QSP workshop group
  3. Wist, 2009, Systems pharmacology and genome medicine: a future perspective, Genome Med, 1, 11, 10.1186/gm11 · DOI
  4. Chibon, 2013, Cancer gene expression signatures–the rise and fall?, Eur J Cancer, 49, 2000, 10.1016/j.ejca.2013.02.021 · DOI · Paper page
  5. Cantini, 2017, Classification of gene signatures for their information value and functional redundancy, NPJ Syst Biol Appl, 4, 2, 10.1038/s41540-017-0038-8 · DOI · Paper page
  6. Shi, 2015, Measures for the degree of overlap of gene signatures and applications to TCGA, Brief Bioinf, 16, 735, 10.1093/bib/bbu049 · DOI
  7. Gönen, 2009, Statistical aspects of gene signatures and molecular targets, Gastrointest Cancer Res, 3, S19
  8. Boran, 2010, Systems approaches to polypharmacology and drug discovery, Curr Opin Drug Discov Devel, 13, 297
  9. Myers, 2015, Differentially expressed genes and signature pathways of human prostate cancer, PLoS One, 10, e0145322, 10.1371/journal.pone.0145322 · DOI
  10. Azmi, 2010, Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations, Mol Cancer Ther, 9, 3137, 10.1158/1535-7163.MCT-10-0642 · DOI · Paper page
  11. Henry, 2014, OMICtools: an informative directory for multi-omic data analysis, Database, 2014, bau069, 10.1093/database/bau069 · DOI · Paper page
  12. Beck, 2014, Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer, Physiol Genomics, 46, 699, 10.1152/physiolgenomics.00062.2014 · DOI
  13. Haider, 2013, Integrated analysis of transcriptomic and proteomic data, Curr Genomics, 14, 91, 10.2174/1389202911314020003 · DOI · Paper page
  14. Yang, 2008, Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis, Dev Cell, 14, 818, 10.1016/j.devcel.2008.05.009 · DOI · Paper page
  15. Gao, 2012, Microenvironmental regulation of epithelial–mesenchymal transitions in cancer, Cancer Res, 72, 4883, 10.1158/0008-5472.CAN-12-1223 · DOI · Paper page
  16. Singh, 2010, EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer, Oncogene, 29, 4741, 10.1038/onc.2010.215 · DOI · Paper page
  17. Thiery, 2006, Complex networks orchestrate epithelial–mesenchymal transitions, Nat Rev Mol Cell Biol, 7, 131, 10.1038/nrm1835 · DOI · Paper page
  18. Pasquier, 2015, Epithelial to mesenchymal transition in a clinical perspective, J Oncol, 2015, 792182, 10.1155/2015/792182 · DOI
  19. Lou, 2008, Epithelial–mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis, Dev Dyn, 237, 2755, 10.1002/dvdy.21658 · DOI · Paper page
  20. Mak, 2016, A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition, Clin Cancer Res, 22, 609, 10.1158/1078-0432.CCR-15-0876 · DOI · Paper page
  21. Gröger, 2012, Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression, PLoS One, 7, e51136, 10.1371/journal.pone.0051136 · DOI · Paper page
  22. Liang, 2016, Meta-analysis of EMT datasets reveals different types of EMT, PLoS One, 11, e0156839, 10.1371/journal.pone.0156839 · DOI
  23. Said, 2013, Strategies and challenges for systematically mapping biologically significant molecular pathways regulating carcinoma epithelial-mesenchymal transition, Cells Tissues Organs, 197, 424, 10.1159/000351717 · DOI
  24. Huang, 2012, Early Events in Cell Adhesion and Polarity during Epithelial-Mesenchymal Transition, 10.1242/jcs.099697 · DOI · Paper page
  25. Clark, 2014, The characteristic direction: a geometrical approach to identify differentially expressed genes, BMC Bioinformatics, 15, 79, 10.1186/1471-2105-15-79 · DOI · Paper page
  26. Tang, 2016, An epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers, Cell Death Dis, 2, 16041, 10.1038/cddiscovery.2016.41 · DOI
  27. Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, pl1, 10.1126/scisignal.2004088 · DOI · Paper page
  28. Voon, 2017, The EMT spectrum and therapeutic opportunities, Mol Oncol, 11, 878, 10.1002/1878-0261.12082 · DOI
  29. Jafari, 2013, Exploring biological processes involved in embryonic stem cell differentiation by analyzing proteomic data, Biochim Biophys Acta, 1834, 1063, 10.1016/j.bbapap.2013.02.003 · doi:10.1016/j.bbapap.2013.02.003
  30. Soundararajan, 2015, A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome, Sci Rep, 5, 11766, 10.1038/srep11766 · DOI
  31. Vetter, 2009, Time-resolved analysis of transcriptional events during SNAI1-triggered epithelial to mesenchymal transition, Biochem Biophys Res Commun, 385, 485, 10.1016/j.bbrc.2009.05.025 · DOI
  32. Tanaka, 2015, Network biology approach to epithelial–mesenchymal transition in cancer metastasis: three stage theory, J Mol Cell Biol, 7, 253, 10.1093/jmcb/mjv035 · DOI
  33. Bedi, 2014, Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer, Oncotarget, 5, 2016, 10.18632/oncotarget.1875 · DOI
  34. 2017, bioRxiv
  35. Lo, 2007, Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression, Cancer Res, 67, 9066, 10.1158/0008-5472.CAN-07-0575 · DOI · Paper page
  36. Devarajan, 2012, Epithelial–mesenchymal transition in breast cancer lines is mediated through PDGF‐D released by tissue‐resident stem cells, Int J Cancer, 131, 1023, 10.1002/ijc.26493 · DOI · Paper page
  37. Gao, 2014, EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition, Hum Pathol, 45, 372, 10.1016/j.humpath.2013.10.001 · DOI
  38. Wu, 2015, Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways, Oncotarget, 6, 29143, 10.18632/oncotarget.5020 · DOI
  39. Asiedu, 2014, AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells, Oncogene, 33, 1316, 10.1038/onc.2013.57 · DOI · Paper page
  40. Barneh, 2013, EphB4 tyrosine kinase stimulation inhibits growth of MDA-MB-231 breast cancer cells in a dose and time dependent manner, Dis Markers, 35, 933, 10.1155/2013/857895 · doi:10.1155/2013/857895
  41. Creedon, 2012, Src kinase inhibitors: promising cancer therapeutics?, Crit Rev Oncog, 17, 145, 10.1615/CritRevOncog.v17.i2.20 · DOI · Paper page
  42. Larue, 2005, Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways, Oncogene, 24, 7443, 10.1038/sj.onc.1209091 · DOI · Paper page
  43. Jin, 2012, ROCK cooperated with ET-1 to induce epithelial to mesenchymal transition through SLUG in human ovarian cancer cells, Biosci Biotechnol Biochem, 76, 42, 10.1271/bbb.110411 · DOI
  44. Wang, 2013, Epithelial–mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer, PLoS One, 8, e56664, 10.1371/journal.pone.0056664 · DOI · Paper page
  45. Brandl, 2010, IKKα controls canonical TGFβ–SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in Panc1 cells, J Cell Sci, 123, 4231, 10.1242/jcs.071100 · DOI · Paper page
  46. Wang, 2016, Extraction and analysis of signatures from the gene expression omnibus by the crowd, Nat Commun, 7, 12846, 10.1038/ncomms12846 · DOI · Paper page
  47. Barneh, 2015, Updates on drug–target network; facilitating polypharmacology and data integration by growth of DrugBank database, Brief Bioinform, 17, 1070
  48. Wishart, 2016, Using DrugBank for in silico drug exploration and discovery, Curr Protoc Bioinformatics, 54, 14.14.1, 10.1002/cpbi.1 · DOI
  49. Krakhmal, 2015, Cancer invasion: patterns and mechanisms, Acta Naturae, 7, 17, 10.32607/20758251-2015-7-2-17-28 · DOI · Paper page
  50. Weigelt, 2014, The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer, Adv Drug Deliv Rev, 69–70, 42, 10.1016/j.addr.2014.01.001 · DOI · Paper page
  51. Aref, 2013, Screening therapeutic EMT blocking agents in a three-dimensional microenvironment, Integr Biol, 5, 381, 10.1039/C2IB20209C · DOI · Paper page
  52. Kim, 2010, Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1, BMC Med Genomics, 3, 51, 10.1186/1755-8794-3-51 · DOI · Paper page
  53. Cheng, 2014, A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype, Breast Cancer Res, 16, 407, 10.1186/s13058-014-0407-9 · DOI
  54. Jia, 2016, A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets, Cancer Lett, 382, 203, 10.1016/j.canlet.2016.09.001 · DOI · Paper page
  55. Mak, 2016, A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial to mesenchymal transition, Clin Cancer Res, 22, 609, 10.1158/1078-0432.CCR-15-0876 · DOI · Paper page
  56. Maere, 2005, BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks, Bioinformatics, 21, 3448, 10.1093/bioinformatics/bti551 · DOI · Paper page
  57. Kuleshov, 2016, Enrichr: a comprehensive gene set enrichment analysis web server 2016 update, Nucleic Acids Res, 44, W90, 10.1093/nar/gkw377 · DOI · Paper page
  58. Feichtinger, 2012, CancerMA: a web-based tool for automatic meta-analysis of public cancer microarray data, Database, 2012, bas055, 10.1093/database/bas055 · DOI
  59. Duan, 2016, L1000CDS2: lINCS L1000 characteristic direction signatures search engine, NPJ Syst Biol Appl, 2, 16015, 10.1038/npjsba.2016.15 · DOI · Paper page
  60. Ma'ayan, 2014, Lean big data integration in systems biology and systems pharmacology, Trends Pharmacol Sci, 35, 450, 10.1016/j.tips.2014.07.001 · DOI · Paper page
  61. Chen, 2012, Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers, Bioinformatics, 28, 105, 10.1093/bioinformatics/btr625 · DOI · Paper page
  62. Jin, 2012, A systems approach identifies HIPK2 as a key regulator of kidney fibrosis, Nat Med, 18, 580, 10.1038/nm.2685 · DOI · Paper page
  63. Lachmann, 2009, KEA: kinase enrichment analysis, Bioinformatics, 25, 684, 10.1093/bioinformatics/btp026 · DOI · Paper page
  64. Tan, 2015, CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype, Oncotarget, 6, 43843, 10.18632/oncotarget.5983 · DOI
  65. Szklarczyk, 2015, STRING v10: protein–protein interaction networks, integrated over the tree of life, Nucleic Acids Res, 43, D447, 10.1093/nar/gku1003 · DOI · Paper page
  66. Jafari, 2015, Interlog protein network: an evolutionary benchmark of protein interaction networks for the evaluation of clustering algorithms, BMC Bioinformatics, 16, 319, 10.1186/s12859-015-0755-1 · DOI
  67. Azimzadeh, 2015, Signaling network of lipids as a comprehensive scaffold for omics data integration in sputum of COPD patients, Biochim Biophys Acta, 1851, 1383, 10.1016/j.bbalip.2015.07.005 · DOI
  68. Ansari-Pour, 2016, Testis-specific Y-centric protein–protein interaction network provides clues to the etiology of severe spermatogenic failure, J Proteome Res, 15, 1011, 10.1021/acs.jproteome.5b01080 · DOI
  69. Rezadoost, 2016, Proteomics of hot-wet and cold-dry temperaments proposed in Iranian traditional medicine: a Network-based Study, Sci Rep, 6, 30133, 10.1038/srep30133 · doi:10.1038/srep30133
  70. Bastian, 2009, Gephi: an open source software for exploring and manipulating networks, ICWSM, 8, 361, 10.1609/icwsm.v3i1.13937 · DOI · Paper page
  71. Shin, 2012, Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels, Nat Protocols, 7, 1247, 10.1038/nprot.2012.051 · DOI · Paper page
  72. Aref, 2013, Screening therapeutic EMT blocking agents in a three-dimensional microenvironment, Integr Biol, 5, 381, 10.1039/C2IB20209C · DOI · Paper page

Cited by

See all 19

Metadata

Authors
Barneh, F., Mirzaie, M., Nickchi, P., Tan, T. Z., Thiery, J. P., Piran, M., Salimi, M., Goshadrou, F., Aref, A. R., & Jafari, M.
Affiliations
  • Department of Basic Sciences, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Department of Applied Mathematics, Faculty of Mathematical Sciences, Tarbiat Modares University, Tehran, Iran
  • Drug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
  • Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599, Singapore, Translational Centre for Development and Research, National University Health System, MD11, #03-10, 10 Medical Drive, Singapore 117597, Singapore
  • Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117596, Singapore
  • Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran
  • Department of Medical Oncology, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston 02215, USA
Venue
Briefings in Bioinformatics
Published
2018-05-02
Volume
20
Issue
2
Pages
717-731
ISSN
1477-4054
Cited by
19
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer. https://app.cochat.ai/papers/10.1093/bib/bby030
The paper
Barneh, F., Mirzaie, M., Nickchi, P., Tan, T. Z., Thiery, J. P., Piran, M., Salimi, M., Goshadrou, F., Aref, A. R., & Jafari, M. (2019). Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bby030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.